Common Stock, Shares, Outstanding of AMICUS THERAPEUTICS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
AMICUS THERAPEUTICS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • AMICUS THERAPEUTICS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 310,853,963, a 4% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

AMICUS THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 310,853,963 +11,812,310 +4% 31 Dec 2025 10-K 20 Feb 2026 2025 FY
Q3 2025 308,499,614 +9,808,520 +3.3% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 308,064,329 +11,635,452 +3.9% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 307,923,069 +11,763,652 +4% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 299,041,653 +5,447,444 +1.9% 31 Dec 2024 10-K 20 Feb 2026 2025 FY
Q3 2024 298,691,094 +8,024,053 +2.8% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 296,428,877 +9,435,954 +3.3% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 296,159,417 +12,858,832 +4.5% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 293,594,209 +12,485,936 +4.4% 31 Dec 2023 10-K 19 Feb 2025 2024 FY
Q3 2023 290,667,041 +9,779,905 +3.5% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 286,992,923 +6,536,256 +2.3% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 283,300,585 +3,166,729 +1.1% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 281,108,273 +2,195,473 +0.79% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 280,887,136 +2,302,044 +0.83% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 280,456,667 +13,924,131 +5.2% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 280,133,856 +14,126,138 +5.3% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 278,912,800 +16,849,339 +6.4% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 278,585,092 +18,984,442 +7.3% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 266,532,536 +8,308,694 +3.2% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 266,007,718 +8,557,763 +3.3% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 262,063,461 +6,645,592 +2.6% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 259,600,650 +4,828,487 +1.9% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 258,223,842 +3,710,320 +1.5% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 257,449,955 +27,269,241 +12% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 255,417,869 +66,033,945 +35% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 254,772,163 +65,517,822 +35% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 254,513,522 +65,460,308 +35% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 230,180,714 +42,208,496 +22% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 189,383,924 +22,394,134 +13% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 189,254,341 +23,763,200 +14% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 189,053,214 +45,681,971 +32% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 187,972,218 +45,142,688 +32% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 166,989,790 +24,297,804 +17% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 165,491,141 +23,218,056 +16% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 143,371,243 +8,962,717 +6.7% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 142,829,530 +17,607,893 +14% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 142,691,986 +17,664,952 +14% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 142,273,085 +17,655,595 +14% 30 Sep 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 134,408,526 +16,041,207 +14% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 125,221,637 +28,846,622 +30% 31 Mar 2016 10-Q 03 May 2016 2016 Q1
Q4 2015 125,027,034 +29,470,757 +31% 31 Dec 2015 10-K/A 03 Mar 2017 2016 FY
Q3 2015 124,617,490 +45,359,902 +57% 30 Sep 2015 10-Q 04 Nov 2015 2015 Q3
Q2 2015 118,367,319 +45,497,458 +62% 30 Jun 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 96,375,015 +32,034,756 +50% 31 Mar 2015 10-Q 05 May 2015 2015 Q1
Q4 2014 95,556,277 +33,580,861 +54% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 79,257,588 +29,625,916 +60% 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 72,869,861 +23,238,189 +47% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 64,340,259 +14,708,587 +30% 31 Mar 2014 10-Q 05 May 2014 2014 Q1
Q4 2013 61,975,416 +12,343,744 +25% 31 Dec 2013 10-K 03 Mar 2015 2014 FY
Q3 2013 49,631,672 +271,013 +0.55% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 49,631,672 +3,253,775 +7% 30 Jun 2013 10-Q 07 Aug 2013 2013 Q2
Q1 2013 49,631,672 +3,255,503 +7% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 49,631,672 +14,977,466 +43% 31 Dec 2012 10-K 03 Mar 2014 2013 FY
Q3 2012 49,360,659 +14,706,453 +42% 30 Sep 2012 10-Q 06 Nov 2012 2012 Q3
Q2 2012 46,377,897 +11,781,088 +34% 30 Jun 2012 10-Q 08 Aug 2012 2012 Q2
Q1 2012 46,376,169 31 Mar 2012 10-Q 11 May 2012 2012 Q1
Q4 2011 34,654,206 +145,274 +0.42% 31 Dec 2011 10-K 03 Mar 2014 2013 FY
Q3 2011 34,654,206 30 Sep 2011 10-Q 02 Nov 2011 2011 Q3
Q2 2011 34,596,809 30 Jun 2011 10-Q 11 Aug 2011 2011 Q2
Q4 2010 34,508,932 31 Dec 2010 10-K 28 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.